Neuromuscular Study Group Inc
Data sourced from IRS 990 public filings
Neuromuscular Study Group Inc To advance knowledge about the cause(s), pathogenesis, epidemiology, and clinical manifestations of muscle disease and related neuromuscular disorders and to develop and implement strategies to examine promising therapeutic interventions
Annual Revenue
$588,959
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $588,959 | $519,092 | $530,512 |
| 2023 | $434,016 | $462,062 | $460,644 |
| 2022 | $278,605 | $425,917 | $488,693 |
| 2021 | $428,433 | $192,454 | $636,005 |
| 2020 | $284,473 | $157,001 | $400,026 |
| 2019 | $461,043 | $371,388 | $272,554 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
Amanda Guidon MD
Investigator Member
Michael Hehir MD
Investigator Member
John Vissing MD
Investigator Member
Michaela Walker MPH CCRP
Coordinator Member
Michael McDermott PhD
Biostatistician
Emma Ciafaloni MD FAAN
Director
James Lilleker MBChB MRCP PhD
Investigator Member
Bhaskar Roy MBB MHS
Young Investigator Member
Richard Barohn MD
Chair
Michael Hanna MD
Co-Chair
Showing 10 of 12 key personnel.
Frequently Asked Questions
Other Nonprofits in Kansas
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.